We are live on ! Find out more
Rafferty Asset Management

Rafferty Asset Management Portfolio holdings

AUM $24.6B
1-Year Est. Return 47.06%
This Fund
S&P 500
This Quarter Est. Return
+10.97%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$19B
AUM Growth
+$4.37B
Cap. Flow
+$3.05B
Cap. Flow %
16.07%
Top 10 Hldgs %
39.91%
Holding
1,362
New
110
Increased
730
Reduced
452
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 35.28%
2 Financials 15.39%
3 Healthcare 5.04%
4 Energy 4.05%
5 Consumer Discretionary 2.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIPO icon
1276
Hippo Holdings
HIPO
$830M
$66K ﹤0.01%
+931
New +$86.8K
YPF icon
1277
YPF
YPF
$20.6B
$66K ﹤0.01%
17,192
-12,132
-41% -$50.8K
IDEX
1278
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$66K ﹤0.01%
439
+78
+22% +$16.6K
LOTZ
1279
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
$64K ﹤0.01%
28,098
+4,968
+21% +$16.3K
NAT icon
1280
Nordic American Tanker
NAT
$1.38B
$63K ﹤0.01%
37,172
+405
+1% +$870
HOFV
1281
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$61K ﹤0.01%
1,829
+265
+17% +$12.5K
UAVS icon
1282
AgEagle Aerial Systems
UAVS
$40.9M
$55K ﹤0.01%
35
+10
+40% +$24.2K
VANI icon
1283
Vivani Medical
VANI
$110M
$55K ﹤0.01%
11,328
+2,283
+25% +$16.7K
GPUS
1284
Hyperscale Data Inc
GPUS
$55.4M
0
ATNX
1285
DELISTED
Athenex, Inc. Common Stock
ATNX
$50K ﹤0.01%
1,821
+421
+30% +$17.8K
XELA
1286
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$49K ﹤0.01%
14
+5
+56% +$29.4K
CTEV
1287
Claritev Corp
CTEV
$387M
$48K ﹤0.01%
271
-212
-44% -$37.8K
KALA icon
1288
KALA BIO
KALA
$14.1M
$47K ﹤0.01%
16
+6
+60% +$27.8K
RNAC icon
1289
Cartesian Therapeutics
RNAC
$229M
$47K ﹤0.01%
478
-4,700
-91% -$506K
ODT
1290
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$47K ﹤0.01%
35,099
+4,998
+17% +$11.8K
SRGA
1291
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$43K ﹤0.01%
+2,002
New +$53.5K
BNGO icon
1292
Bionano Genomics
BNGO
$12.3M
$41K ﹤0.01%
+23
New +$61.5K
BBIG
1293
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$41K ﹤0.01%
1,281
-961
-43% -$56.2K
MTNB icon
1294
Matinas BioPharma
MTNB
$1.88M
$35K ﹤0.01%
+688
New +$36.8K
RESN
1295
DELISTED
Resonant Inc.
RESN
$19K ﹤0.01%
+11,323
New +$24.4K
ELOX
1296
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$18K ﹤0.01%
+652
New +$28.4K
MUX icon
1297
McEwen Inc
MUX
$1.03B
$17K ﹤0.01%
+1,933
New +$20.1K
XCUR icon
1298
Exicure
XCUR
$10.2M
$6K ﹤0.01%
+192
New +$22.3K
BDN
1299
Brandywine Realty Trust
BDN
$524M
-11,039
Closed -$148K
CAC icon
1300
Camden National
CAC
$978M
-4,620
Closed -$221K

Similar funds

Rafferty Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Rafferty Asset Management held 1,362 positions worth $19B, up 30% from $14.6B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Rafferty Asset Management deployed $3.05B of net new capital in Q4 2021, opening 110 new positions and adding to 730 existing holdings. Its largest new stake was Aflac: 345,009 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $81.8M trimmed.

  • Rafferty Asset Management's largest Q4 2021 buy was Aflac: 345,009 shares worth $20.1M.
  • Rafferty Asset Management added most to iShares Core S&P 500 ETF in Q4 2021, an estimated $492M increase.
  • Rafferty Asset Management's biggest Q4 2021 reduction was VanEck Gold Miners ETF, cutting an estimated $81.8M.
  • Rafferty Asset Management fully exited CIMAREX ENERGY CO in Q4 2021, selling an estimated $8.07M.
  • Rafferty Asset Management's ten largest holdings make up 40% of its $19B portfolio in Q4 2021.
  • Rafferty Asset Management opened 110 new positions and closed 64 in Q4 2021.
  • Rafferty Asset Management's portfolio value rose 30% quarter-over-quarter to $19B.

Based on Rafferty Asset Management's 13F filing for Q4 2021, filed 10 Feb 2022.